基于网络药理学和分子对接技术探究大承气汤治疗便秘作用机制
Investigating the Mechanism of Action of Dachengqi Decoction in the Treatment of Constipation Based on Network Pharmacology and Molecular Docking Technology
DOI: 10.12677/tcm.2025.145344, PDF,   
作者: 李欣凝, 黄楠楠*, 王立运:黑龙江中医药大学药学院,黑龙江 哈尔滨;宋健平:黑龙江中医药大学研究生院,黑龙江 哈尔滨
关键词: 大承气汤便秘网络药理学分子对接技术Dachengqi Decoction Constipation Network Pharmacology Molecular Docking Technology
摘要: 目的:运用网络药理和分子对接技术探究大承气汤治疗便秘的有效成分、作用靶点、信号通路及分子机制。方法:运用TCMSP数据库遴选大承气汤中的有效成分、作用靶点;通过GeneCards、OMIM、TTD、DrugBank数据库以“constipation”为检索词进行搜集得到便秘相关靶点;利用Cytoscape 3.10.0软件构建“药物成分–潜在作用靶点”网络关系图;再导入String数据库生成靶点蛋白质互作关系图。本研究采用Metascape对核心作用靶点开展功能标注分析,即基因本体及京都基因与基因组百科全书通路富集分析。同时,运用Autodock分子对接技术模拟配体–受体相互作用,从分子层面验证活性成分与关键靶蛋白的结合稳定性与亲和力。结果:获得大承气汤治疗便秘的相关活性成分有木犀草素、柚皮素、β-谷甾醇、川陈皮素等。核心靶点有RAC-alpha serine/threonine-protein kinase (RAC-α丝氨酸/苏氨酸蛋白激酶)、Cellular tumor antigen p53 (肿瘤蛋白p53)、Tumor necrosis factor (肿瘤坏死因子)、Epidermal growth factor receptor(表皮生长因子受体)、Interleukin-6 (白细胞介素-6)等。GO富集分析共得生物学过程(BP) 323条、细胞组成(CC) 101条、分子功能(MF) 144条,KEGG通路有205条。分子对接结果表明,大承气汤有效成分与其作用靶点稳定结合。结论:大承气汤是通过多条通路、多种成分、多个靶点治疗便秘。
Abstract: Objective: Investigating the active ingredients, targets, signalling pathways and molecular mechanisms of Dachengqi Decoction for the curing of constipation by using network pharmacology and molecular docking. Methods: The TCMSP database was utilised to select the main effective Chinese medicines and targets in Dachengqi Decoction for the treatment of constipation; GeneCards, OMIM, TTD, and DrugBank databases were used to obtain constipation-related targets by using the search term “constipation”; Cytoscape 3.10.0 database was used to construct a network diagram of “drug components-potential targets”, and then imported into the String database to generate a network diagram of target-protein interfaces. In this study, the Metascape bioinformatics system was used to annotate the core targets, comprising gene ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment. Meanwhile, Autodock molecular docking technology was applied to simulate ligand-receptor interactions to verify the binding stability and affinity of the active ingredient with key target proteins at the molecular level. Results: Some relevant active ingredients of Dachengqi Decoction for the treatment of constipation were obtained, including lignans, naringenin, β-sitosterol, and chuan chenpianin. The core targets were RAC-alpha serine/threonine-protein kinase (RAC-alpha serine/threonine-protein kinase), Cellular tumor antigen p53 (tumour protein p53), and Tumor necrosis factor (TNF), Epidermal growth factor receptor (EGFR), Interleukin-6 (Ileukin-6), etc. The GO enrichment analysis yielded a total of 323 biological processes (BP), 101 cellular components (CC), 144 molecular functions (MF), and 205 KEGG pathways. The findings of molecular docking showed that the active ingredients of Dachengqi Decoction were stably bound to their targets. Conclusion: Dachengqi Decoction treats constipation through multiple multiple pathways, multiple composition and multiple targets.
文章引用:李欣凝, 黄楠楠, 王立运, 宋健平. 基于网络药理学和分子对接技术探究大承气汤治疗便秘作用机制[J]. 中医学, 2025, 14(5): 2319-2331. https://doi.org/10.12677/tcm.2025.145344

参考文献

[1] 赵进喜, 贾海忠, 张立山, 等. 仲景“下法”, 意在逐邪; 因势利导, 辨证为先[J]. 环球中医药, 2017, 10(3): 306-310.
[2] 南京中医学大学, 编著. 伤寒论[M]. 上海: 上海科学技术出版社, 2018.
[3] 何伦, 顿宝生. 常用类方鉴别运用(十二) [J]. 陕西中医, 1984, 5(12): 33-34.
[4] 李冀. 方剂学[M]. 第2版. 北京: 中国中医药出版社, 2016: 111-114.
[5] 牛明, 张斯琴, 张博, 等. 《网络药理学评价方法指南》解读[J]. 中草药, 2021, 52(14): 4119-4129.
[6] 王焘. 外台秘要方[M]. 北京: 人民卫生出版社, 1982: 184, 194.
[7] 陶凌辉, 陈明显, 傅睿, 等. 大承气汤的源流及历代应用探究[J]. 中医文献杂志, 2022, 40(6): 39-42.
[8] 张蕊, 杨宗亮, 胡响当. 大承气汤辨治痔术后阳明腑实证便秘验案[J]. 光明中医, 2024, 39(23): 4804-4806.
[9] Yang, M., Zhou, Y., Wan, L., Ye, J., Lu, H., Huang, X., et al. (2020) Luteolin Suppresses Colonic Smooth Muscle Motility via Inhibiting L-Type Calcium Channel Currents in Mice. General Physiology and Biophysics, 39, 49-58. [Google Scholar] [CrossRef] [PubMed]
[10] 康蕾, 梁磊, 洪关婷, 等. 基于网络药理学及分子对接方法探析厚朴三物汤治疗便秘的机制研究[J]. 现代药物与临床, 2024, 39(2): 335-341.
[11] 陈孟瑶, 乐音子, 颜帅. 柚皮素治疗消化系统疾病的药理作用及机制研究进展[J]. 中草药, 2024, 55(13): 4622-4632.
[12] 陈元堃, 曾奥, 罗振辉, 等. β-谷甾醇药理作用研究进展[J]. 广东药科大学学报, 2021, 37(1): 148-153.
[13] 杨静帆, 李敏艳, 秦燕勤, 等. 川陈皮素的药理活性研究进展[J]. 中医学报, 2023, 38(4): 719-725.
[14] 郭伟, 彭琛, 王一坤, 等. 基于PI3K/Akt信号通路探讨中医药治疗食管癌的研究进展[J/OL]. 中国实验方剂学杂志: 1-20. 2025-04-03.[CrossRef
[15] 宋德琴, 黄雪婷, 杜冉, 等. 基于网络药理学和分子对接探讨香连丸治疗腹泻作用机制[J]. 中国中医药图书情报杂志, 2025, 49(1): 38-43.
[16] 胡溪, 冯立, 高智, 等. 大黄素调节TLR4/MyD88/NF-κB信号通路对慢性肾功能衰竭大鼠肠道菌群结构的影响[J/OL]. 中国医院药学杂志: 1-9.
http://kns.cnki.net/kcms/detail/42.1204.R.20241129.1751.006.html, 2025-04-03.
[17] 孙芙蓉, 孙雪梅, 隋秀林, 等. 基于“态靶辨证”理论探究乌梅丸加味方在表皮生长因子受体-酪氨酸激酶抑制剂治疗非小细胞肺癌导致相关性腹泻中的作用[J]. 中国民间疗法, 2025, 33(1): 124-128.
[18] 陈婷玉, 方凤贞. 参芪薏苡仁粥介导Toll样受体4/核因子-κB通路调控化疗后大鼠血清白细胞介素-6、肿瘤坏死因子-α及肠道紧密连接蛋白的机制研究[J]. 中医临床研究, 2022, 14(20): 9-12.
[19] Siveen, K.S., Sikka, S., Surana, R., Dai, X., Zhang, J., Kumar, A.P., et al. (2014) Targeting the STAT3 Signaling Pathway in Cancer: Role of Synthetic and Natural Inhibitors. Biochimica et Biophysica Acta (BBA)—Reviews on Cancer, 1845, 136-154. [Google Scholar] [CrossRef] [PubMed]
[20] 李子玉, 袁洋. 溃疡性结肠炎患者肠道菌群分布与血清TNF-α、IL-6水平的相关性[J]. 中国肛肠病杂志, 2024, 44(8): 44-46.